Scientists at UCI reveal that skin cells use microscopic “cellular bridges” called cytonemes to coordinate renewal, a process that may hold keys to treating skin diseases.

UCI researchers uncover how the lipid sphingosine can shut down cancer-driving signals — offering hope for tackling drug resistance.

UCI scientists use math and biology to uncover how Chlamydia times its switch to an infectious state — a finding that may inspire new therapies.

UCI researchers discover the “range extender,” a DNA element that lets enhancers control genes from far away — reshaping our understanding of gene regulation.

A UCI team develops SigXTalk, an AI-powered tool that maps how cells communicate — and miscommunicate — in health and disease.

A new study sheds light on how melanoma, a dangerous form of skin cancer, can arise even from minimal genetic changes.

The Lander Lab at UCI finds that immune cells join the fight in “cell competition,” helping tissues weed out weak or cancerous cells.

The Tom Angell Fellowship award is awarded annually and intended to honor Tom Angell’s contributions as the UCI Graduate Counselor

The interdisciplinary program project grant, “Tipping points in cancer” has been funded for five years by the National Cancer Institute

Congratulations to Sydney Prange, a graduate student in the lab of Prof. Katie Thompson-Peer. Sydney Prange earned second place in